0 CHECKOUT

PRODUCT FILTERS

REGION

440
69
39
38
29

COUNTRY

36
19
6
6
6

PRICE

275
516
1,055
1,529

PUBLISHED

60
81
288
1,529

PRODUCT TYPE

1,508
14
5
2

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

1,529 Products

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) Trends & Global Forecast to 2020

Over the years, the global healthcare industry has witnessed a paradigm shift, and is now increasingly focused on minimally invasive therapies that not only treats a wide range of chronic and refractory...

Published:  July 2015
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  August 2015
Price:  From
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

Published:  August 2015
Price:  From
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Internal Neurostimulation Market, by Type, by Application, and by Geography – Analysis & Forecasts to 2019

Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application (Parkinson’s...

Published:  April 2015
Price:  From

Global Anxiety Disorders Market 2015-2019

About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response....

Published:  January 2015
Price:  From

Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market- Forecasts till 2019

Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market [Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve...

Published:  February 2015
Price:  From

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities

This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental minimally-invasive...

Published:  September 2014
Price:  From

Inhaled CNS Therapeutics

Neurological disorders are highly prevalent worldwide And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden...

Published:  June 2014
Price:  From

Brain Monitoring Market [By Product [EEG/Magnetoencephalography (MEG)/ Intracranial Pressure Monitor/Cerebral Oximeter/ Transcranial Doppler] & Application [Sleep Disorders/ Epilepsy/Traumatic Brain Injury/Brain Death] – Global Forecasts to 2017

The global brain monitoring devices market was valued at $1 08 billion in 2012, and is poised to grow at a CAGR of 8 6% to reach $1 63 billion by 2017 The market offers a variety of brain monitoring...

Published:  February 2013
Price:  From

Vimpat-Drug Insights,2014

“Vimpat - Drug Insights, 2014” provides Vimpat marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

Published:  August 2015
Price:  From

Vyvanse-Drug Insights,2014

“Vyvanse - Drug Insights, 2014” provides Vyvanse marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

Published:  August 2015
Price:  From

Versatis-Drug Insights,2014

“Versatis - Drug Insights, 2014” provides Versatis marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

Published:  August 2015
Price:  From

Vigil-Drug Insights,2014

“Vigil - Drug Insights, 2014” provides Vigil marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

Published:  August 2015
Price:  From

Xenazine-Drug Insights,2014

“Xenazine - Drug Insights, 2014” provides Xenazine marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

Published:  August 2015
Price:  From

Neurontin-Drug Insights,2014

“Neurontin - Drug Insights, 2014” provides Neurontin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

Published:  August 2015
Price:  From

Subridion-Drug Insights,2014

“Subridion - Drug Insights, 2014” provides Subridion marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

Published:  August 2015
Price:  From

Xanax-Drug Insights,2014

“Xanax XR - Drug Insights, 2014” provides Xanax XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

Published:  August 2015
Price:  From

Risperdal Consta LP-Drug Insights,2014

“Risperdal Consta LP - Drug Insights, 2014” provides Risperdal Consta LP marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

Published:  August 2015
Price:  From

Rebif-Drug Insights,2014

“Rebif - Drug Insights, 2014” provides Rebif marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

Published:  August 2015
Price:  From
Loading Indicator

Our Clients